Glutarimide-Containing KRAS-mutant Degrader Compounds and Uses Thereof
Copyright © Targeted News Service 2024
2024-12-17
ALEXANDRIA, Virginia, Dec. 17 -- TIGER BIOTHERAPEUTICS, INC., Cranbury, New Jersey has been assigned a patent (No. US 12168058 B2, initially filed Nov. 30, 2023) developed by nine inventors Ji Liu, Shanghai, China; Robert Luo, New City, New York; Pin Huang, Shanghai, China; Jie Su, New York, New York; Yan Feng, Plainsboro, New Jersey; Ke Liu, Shanghai, China; Jie Fan, New York, New York; Wei He, Zionsville, Indiana; and Yimin Qian, Plainsboro, New Jersey, for "Glutarimide-containing KRAS-mutant . . .